This Rare Cancers Awareness Day, Icon Cancer Centre is proud to spotlight the impact of their national partnership with Rare Cancers Australia (RCA), uniting RCA’s advocacy with Icon’s 45 centres and more than 300 doctors across Australia.
Together, we’re bridging critical gaps in care for patients facing rare and less common cancers.
Patients with a rare cancera disease where abnormal cells split without control and spread to other nearby body tissue and/or organs often describe their journey as isolating and uncertain, with delayed diagnoses and fragmented support. For those in regional or outer metro areas, these challenges are compounded by long travel times and limited access to trials and specialist care.
Through this partnership, patients are gaining faster, more direct connection to the vital services RCA provides.
Icon is advancing innovation through its national research program, and partnership with Omico, helping bring genomic-enabled clinical trialsresearch studies performed to test new treatments, tests or procedures and evaluate their effectiveness on various diseases closer to home.
Access to comprehensive genomic profiling is enabling faster, more accurate diagnoses and driving a major shift towards personalised treatment plans.
By generating the real-world evidence needed to support this approach, we’re working to embed personalised care into the standard cancer treatment pathway, ensuring innovation reaches every patient.
As Australia’s largest dedicated cancer care provider, Icon Cancer Centre delivers integrated services across medical oncologythe study, diagnosis and treatment of cancer, haematologythe study of blood and related diseases, radiation oncology, research and theranostics.
With 30% of centres in regional areas and 50% in outer-metro and regional communities, Icon is committed to delivering care closer to home.
Icon is also focused on driving lasting change by advocating for equitable access, sustainable funding models, and personalised treatment for every patient, no matter how rare their diagnosisthe process of identifying a disease based on signs and symptoms, patient history and medical test results or where they live.